Glucobay M 25 Tablet is an oral medication prescribed for the management of type 2 diabetes mellitus in adults. This medication assists in regulating blood glucose levels in individuals diagnosed with this condition. To maximize its effectiveness, it is recommended that the tablet be taken during meals, and adherence to a consistent daily schedule is crucial. Your healthcare provider will determine the appropriate dosage tailored to your specific needs, which may be adjusted based on your response to the medication and your blood glucose readings. It is important to continue using this medication even if you feel well or believe your blood sugar is under control. Discontinuing the drug without medical guidance could result in increased blood sugar levels, which poses serious risks such as kidney damage, vision loss, nerve complications, and amputations. Alongside this treatment, following your healthcare provider’s advice regarding nutrition, regular physical activity, and managing your weight can significantly influence your ability to control diabetes. Some of the frequently reported side effects associated with this medication include gas, loose stools, stomach discomfort, water retention, and elevated liver enzymes; these side effects are generally transient and tend to resolve independently. If any side effects persist or cause concern, it is advisable to seek guidance from your healthcare provider, who may recommend strategies for alleviating these symptoms. Notably, this medication is not suitable for individuals with type 1 diabetes, diabetic ketoacidosis, or those experiencing severe renal or hepatic impairment. Prior to initiating treatment, it is crucial to disclose any history of heart disease to your physician. Regular monitoring of blood sugar levels, along with potential blood tests to evaluate blood cell counts and liver health, is essential during the course of this treatment.
-15%

GLUCOBAY M 25
Original price was: ₹111.60.₹95.20Current price is: ₹95.20.
Add to cart
Buy Now

Reviews
There are no reviews yet.